IPP Bureau
Heartfulness signs hits a new milestone by signing an MoU with AIIMS
By IPP Bureau - March 30, 2023
CAHO and Dozee join hands to discuss emerging role of AI in healthcare
By IPP Bureau - March 30, 2023
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine
By IPP Bureau - March 30, 2023
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Granules India inaugurates packaging facility in Virginia
By IPP Bureau - March 30, 2023
The facility is over 79,000 square feet and is equipped with packaging lines
Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare
By IPP Bureau - March 29, 2023
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
Zydus receives final approval from USFDA for Loperamide Hydrochloride Capsules
By IPP Bureau - March 29, 2023
Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States
Vijaya Medical and Educational Trust, Vadapalani adopts AI-based monitoring technology
By IPP Bureau - March 29, 2023
Vijaya Hospital, Chennai adopted Dozee’s AI-based contactless continuous remotemonitoring and early warning system to enhance patient safety
Sanofi receives marketing approval for its diabetes drug Soliqua in India
By IPP Bureau - March 29, 2023
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
Thalassemics India celebrates 35 years of service in Thalassemia
By IPP Bureau - March 29, 2023
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Agilent presents 2023 Darlene Solomon Award to Kathryn Wolhuter
By IPP Bureau - March 28, 2023
The award recognizes and supports promising female scientists working in mass spectrometry
Thermo Fisher Scientific opens cell therapy facility at University of California
By IPP Bureau - March 28, 2023
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Govt. reviews public health preparedness for management of COVID-19
By IPP Bureau - March 28, 2023
States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources
Integrated strategy needed to achieve 'TB Mukt Bharat'
By IPP Bureau - March 28, 2023
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
Lupin receives tentative approval from USFDA for Valbenazine capsules
By IPP Bureau - March 28, 2023
Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVIA MAT December 2022).
Briefs: Morepen Laboratories and Zydus Lifesciences
By IPP Bureau - March 27, 2023
The company is addressing these observations
